Checkout View Cart Items

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells Obtain the highest quality cells for your reprogramming experiments

  • Expand & reprogram your somatic cells in optimized media with validated methods
  • Select & expand your iPS cells with industry-standard stem cell media
  • Validate with a wide range of histochemical & molecular methods
  • Differentiate to your lineage of choice with our kits, growth factors & supplements

We value your input: participate in our online survey on iPSC research

Invitrogen Offers Solutions for Every Step of the iPSC Workflow



Step 1.  Media, reagents & somatic cells for reprogramming

  • Primary fibroblast and keratinocyte cells
  • Optimized GIBCO® culture media and reagents for efficient cell expansion




Step 2.  Reprogram your somatic cells with maximal efficiency

  • Invitrogen’s ViraPower™ HiPerform™ iPSC lentiviral products




Step 3.  Selection & expansion with induced pluripotent stem cell media & reagents

  • Fully validated GIBCO® media, substrates, reagents and freezing media designed to enhance iPS cell growth and expansion



Step 4.  Validate pluripotency with induced pluripotent stem cell antibodies

  • Kits and antibodies to ensure your cells have achieved pluripotency



Step 5.  Differentiate your cells with induced pluripotent stem cell growth factors & cytokines

  • Growth factors and cytokines for targeted differentiation of iPSCs

About Induced Pluripotent Stem Cells

  • The discovery in 2006 that human and mouse fibroblasts could be reprogrammed to generate induced pluripotent stem cells(1-3) (iPSC) with qualities remarkably similar to embryonic stem cells has created a valuable new source of pluripotent cells for drug discovery, cell therapy, and basic research.

    Invitrogen products have been an integral part of iPSC research from the initial discovery of iPSCs(1-4) to current breakthroughs.(5-7)  Our broad technology platform provides optimized tools for each step of your pluripotent stem cell (iPSC) workflow: from isolation and expansion of somatic cells to validation and
    differentiation of iPSCs.